Sponsor Pipeline

Immunomic Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-31 NCT07652242
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative…		 Trial arms changed: 3 -> 5
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-07-24 NCT07726147 Phase 1, First in Human (FIH), Open-Label, Single-Arm, Ascending Dose Study to Assess the… Phase 1 Recruiting
Active Trials by Phase
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07726147 Phase 1, First in Human (FIH), Open-Label, Single-Arm, Ascending Dose Study to Assess the… Allergen Immunotherapy Recruiting
NCT07652242 Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative… Triple Negative Breast Cancer (TNBC) Recruiting
Disease Areas
Breast Cancer (1) Triple-Negative Breast Cancer (1)
Get alerts when Immunomic Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free